Joe Mclane, Merck
I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers.
Joe McLane
Senior Manager, Global Marketing Communications, HPV Franchise, Merck
I joined Merck in 1996 as a customer account representative, processing pharmaceutical and vaccine orders for our direct customers. I wanted to have a career in pharma, and. more importantly, at Merck, because I wanted to be part of something bigger and make a difference. My major accomplishments so far include "Tell Someone," a disease campaign that educated women on the link between cervical cancer and human papillomavirus, and the launch of "One Less," our branded campaign that announced the availability of [HPV vaccine] Gardasil.
Social networks are the new frontier for pharma. Social networks, word-of-mouth initiatives, and other social media will help stimulate conversations. Consumers trust healthcare information they learn in social circles; we are now exploring how to work with these unique networks to further our messages.
In 10 years, I hope to be doing what I love to do with people who are as passionate as I am. I'm trying to convince myself that 40 is the new 30.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
